SITANOW-50
MRP: 1,600
Packaging: 10x10
Pack Type: tablet
Composition:
Sitagliptin 50mg
Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Description:
Sitagliptin 50 mg is an oral medication used in the treatment of type 2 diabetes mellitus. It belongs to the class of DPP-4 (Dipeptidyl Peptidase-4) inhibitors, which help increase the levels of incretin hormones. These hormones stimulate insulin release and suppress glucagon secretion in response to elevated blood glucose levels.
This helps improve blood sugar control by lowering both fasting and postprandial glucose levels. Sitagliptin 50 mg is often prescribed alone or in combination with other antidiabetic agents such as metformin or sulfonylureas to achieve better glycemic control.
Tags:
- Enhances blood glucose regulation by increasing incretin hormones
- Reduces HbA1c and post-meal glucose levels
- Low risk of hypoglycemia when used alone
- Convenient oral once-daily dosing
- Can be combined with other diabetes medicines
Usage Information
Dosage
Take 50 mg once daily as prescribed Can be taken with or without food Follow your healthcare provider’s instructions strictly Do not crush or chew the tablet
Side Effects
Nasopharyngitis (cold symptoms) Headache Upper respiratory tract infections Hypoglycemia (mainly with insulin or sulfonylureas) Rare allergic reactions Seek medical attention if you experience severe allergic symptoms or unusual side effects.
Contraindications
Type 1 diabetes mellitus Diabetic ketoacidosis Allergy to Sitagliptin or tablet ingredients Not approved for children under 18 years without medical advice
Availability
Sitagliptin 50 mg DPP-4 inhibitor diabetes drug Oral antidiabetic medication Type 2 diabetes treatment Blood sugar control tablets Sitagliptin for diabetes Diabetes oral medication